Tele-Oncology: A Validation Study of Choroidal and Iris Nevi.
Choroidal nevus
Iris nevus
Ocular oncology
Telemedicine
Journal
Ocular oncology and pathology
ISSN: 2296-4681
Titre abrégé: Ocul Oncol Pathol
Pays: Switzerland
ID NLM: 101656139
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
received:
27
06
2018
accepted:
30
10
2018
entrez:
2
8
2019
pubmed:
2
8
2019
medline:
2
8
2019
Statut:
ppublish
Résumé
To evaluate teleophthalmological assessment of choroidal and iris nevi (tele-oncology) compared to traditional in-person clinical evaluation for detection of either axial or basal growth. This is a validation study. All 97 eyes of 99 patients were evaluated with an in-person ocular oncology visit utilizing standard testing, and subsequently had a tele-oncology evaluation with the standardized tests. The tele-oncology reviewer was blinded to the in-person examination findings. The primary study outcome was detection of nevus growth on tele-oncology compared to in-person clinical examination. Patients had a mean age of 61 years and the majority had nevi located in the choroid ( The results of this study suggest that tele-oncology is a safe platform for monitoring choroidal and iris nevi for growth, with excellent sensitivity, specificity, PPV, and NPV.
Sections du résumé
BACKGROUND/AIMS
OBJECTIVE
To evaluate teleophthalmological assessment of choroidal and iris nevi (tele-oncology) compared to traditional in-person clinical evaluation for detection of either axial or basal growth.
METHODS
METHODS
This is a validation study. All 97 eyes of 99 patients were evaluated with an in-person ocular oncology visit utilizing standard testing, and subsequently had a tele-oncology evaluation with the standardized tests. The tele-oncology reviewer was blinded to the in-person examination findings. The primary study outcome was detection of nevus growth on tele-oncology compared to in-person clinical examination.
RESULTS
RESULTS
Patients had a mean age of 61 years and the majority had nevi located in the choroid (
CONCLUSIONS
CONCLUSIONS
The results of this study suggest that tele-oncology is a safe platform for monitoring choroidal and iris nevi for growth, with excellent sensitivity, specificity, PPV, and NPV.
Identifiants
pubmed: 31367594
doi: 10.1159/000494977
pii: oop-0005-0298
pmc: PMC6615321
doi:
Types de publication
Journal Article
Langues
eng
Pagination
298-302Déclaration de conflit d'intérêts
No funding was received for this study. None of the authors have any financial disclosures to make or proprietary interests/conflicts of interest to declare.
Références
Arch Ophthalmol. 2000 Mar;118(3):360-4
pubmed: 10721958
Arch Ophthalmol. 2009 Mar;127(3):314-9
pubmed: 19273796
Arch Ophthalmol. 2009 Aug;127(8):981-7
pubmed: 19667334
Arch Ophthalmol. 2009 Aug;127(8):989-98
pubmed: 19667335
Diabet Med. 2010 Mar;27(3):249-56
pubmed: 20536486
Ophthalmology. 2011 Feb;118(2):382-8
pubmed: 20801518
Curr Opin Ophthalmol. 2011 May;22(3):194-8
pubmed: 21460727
Ophthalmology. 2011 Dec;118(12):2468-73
pubmed: 21820181
Cancer. 1990 Oct 1;66(7):1596-600
pubmed: 2208011
Br J Ophthalmol. 2012 Jun;96(6):783-7
pubmed: 22452836
Can J Ophthalmol. 2013 Jun;48(3):160-6
pubmed: 23769776
Clin Ophthalmol. 2013;7:1669-82
pubmed: 24003303
Ophthalmology. 2013 Dec;120(12):2604-2610
pubmed: 24084501
Ophthalmology. 2014 Jun;121(6):1281-8
pubmed: 24480708
JAMA Ophthalmol. 2014 Oct;132(10):1178-84
pubmed: 24970095
PLoS One. 2014 Dec 05;9(12):e113779
pubmed: 25479593
Br J Ophthalmol. 2016 May;100(5):665-70
pubmed: 26347525
Am J Ophthalmol. 2016 Feb;162:20-27.e1
pubmed: 26596399
Curr Oncol. 2016 Feb;23(1):e57-64
pubmed: 26966414
JAMA Ophthalmol. 2016 Jul 1;134(7):734-40
pubmed: 27123792
Ophthalmology. 2017 Dec;124(12):1729-1734
pubmed: 28647202
Can J Ophthalmol. 2018 Oct;53(5):471-473
pubmed: 30340713
Arch Ophthalmol. 1998 May;116(5):645-50
pubmed: 9596501